Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2

Z M Goeckeler1, R A Masaracchia, Q Zeng

  • 1Departments of Pathology and Anesthesiology, St. Louis University School of Medicine, St. Louis, Missouri 63104-1028, USA.

Insights

PAK2 directly inhibits myosin light chain kinase (MLCK) activity by phosphorylating it. This action reduces myosin II RLC phosphorylation, thereby limiting cell contraction and tension development.

Area of Science:

  • Cellular biology
  • Molecular mechanisms of contraction

Background:

  • Myosin II regulatory light chain (RLC) phosphorylation by Ca(2+)/calmodulin-dependent myosin light chain kinase (MLCK) drives smooth muscle and non-muscle cell contraction.
  • Post-translational modifications of MLCK can decrease its activity, reducing RLC phosphorylation and myosin II activation.

Purpose of the Study:

  • To investigate the role of PAK2 in regulating isometric tension development and myosin II RLC phosphorylation in endothelial cells.
  • To determine if PAK2 directly modulates MLCK activity.

Main Methods:

  • Utilized saponin-permeabilized endothelial monolayers to study isometric tension.
  • Assessed myosin II RLC phosphorylation and diphosphorylation.
  • Performed in vitro phosphorylation assays using Cdc42-activated and constitutively active PAK2 on MLCK.
  • Identified phosphorylation sites on MLCK using mass spectrometry.

Main Results:

  • PAK2 significantly reduced isometric tension development by 75% and inhibited myosin II RLC diphosphorylation.
  • PAK2 directly phosphorylated MLCK in vitro, with a stoichiometry of 1.71 mol PO(4)/mol MLCK.
  • PAK2-mediated phosphorylation of MLCK inhibited its ability to phosphorylate myosin II RLC.
  • PAK2 phosphorylated MLCK at Serine 439 and 991; calmodulin binding to MLCK prevented Ser-991 phosphorylation.

Conclusions:

  • PAK2 directly phosphorylates and inhibits MLCK activity.
  • This inhibition of MLCK by PAK2 limits myosin II RLC phosphorylation and subsequent isometric tension development.
  • PAK2 acts as a negative regulator of cell contraction by targeting MLCK.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...